• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mesenchymal stem cells-derived exosomes ameliorate nucleus pulposus cells apoptosis via delivering miR-142-3p: therapeutic potential for intervertebral disc degenerative diseases.间充质干细胞衍生的外泌体通过递送 miR-142-3p 减轻髓核细胞凋亡:治疗椎间盘退行性疾病的潜力。
Cell Cycle. 2020 Jul;19(14):1727-1739. doi: 10.1080/15384101.2020.1769301. Epub 2020 Jun 17.
2
Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration.间充质干细胞通过外泌体传递外源性 miR-21 抑制髓核细胞凋亡,减少椎间盘退变。
J Cell Mol Med. 2018 Jan;22(1):261-276. doi: 10.1111/jcmm.13316. Epub 2017 Aug 14.
3
Exosomes Derived from Human Placental Mesenchymal Stromal Cells Carrying AntagomiR-4450 Alleviate Intervertebral Disc Degeneration Through Upregulation of ZNF121.人胎盘间充质干细胞来源的外泌体通过上调 ZNF121 缓解椎间盘退变
Stem Cells Dev. 2020 Aug;29(16):1038-1058. doi: 10.1089/scd.2020.0083. Epub 2020 Jul 27.
4
Therapeutic effect of co-culture of rat bone marrow mesenchymal stem cells and degenerated nucleus pulposus cells on intervertebral disc degeneration.大鼠骨髓间充质干细胞与退变髓核细胞共培养对椎间盘退变的治疗作用。
Spine J. 2021 Sep;21(9):1567-1579. doi: 10.1016/j.spinee.2021.05.007. Epub 2021 May 14.
5
Exosomes derived from Mouse Bone Marrow Mesenchymal Stem Cells Attenuate Nucleus Pulposus Cell Apoptosis via the miR-155- 5p/Trim32 Axis.鼠骨髓间充质干细胞来源的外泌体通过 miR-155-5p/Trim32 轴减轻髓核细胞凋亡。
Curr Mol Med. 2024;24(8):1045-1055. doi: 10.2174/1566524023666230816090843.
6
Mesenchymal stem cell exosomes inhibit nucleus pulposus cell apoptosis via the miR-125b-5p/TRAF6/NF-κB pathway axis.间质干细胞外泌体通过 miR-125b-5p/TRAF6/NF-κB 通路轴抑制髓核细胞凋亡。
Acta Biochim Biophys Sin (Shanghai). 2023 Dec 25;55(12):1938-1949. doi: 10.3724/abbs.2023241.
7
Bone mesenchymal stem cells deliver exogenous lncRNA CAHM via exosomes to regulate macrophage polarization and ameliorate intervertebral disc degeneration.骨间充质干细胞通过外泌体传递外源性长链非编码 RNA CAHM 来调节巨噬细胞极化并改善椎间盘退变。
Exp Cell Res. 2022 Dec 15;421(2):113408. doi: 10.1016/j.yexcr.2022.113408. Epub 2022 Nov 2.
8
Mesenchymal stem cells-derived exosomes ameliorate intervertebral disc degeneration through inhibiting pyroptosis.间质干细胞衍生的外泌体通过抑制细胞焦亡来改善椎间盘退变。
J Cell Mol Med. 2020 Oct;24(20):11742-11754. doi: 10.1111/jcmm.15784. Epub 2020 Aug 29.
9
Wharton's Jelly-derived mesenchymal stem cells suppress apoptosis of nucleus pulposus cells in intervertebral disc degeneration via Wnt pathway.牙髓间充质干细胞通过 Wnt 通路抑制椎间盘退变中髓核细胞的凋亡。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):9807-9814. doi: 10.26355/eurrev_202010_23190.
10
Exosomal miR-532-5p from bone marrow mesenchymal stem cells reduce intervertebral disc degeneration by targeting RASSF5.骨髓间充质干细胞来源的外泌体 miR-532-5p 通过靶向 RASSF5 减少椎间盘退变。
Exp Cell Res. 2020 Aug 15;393(2):112109. doi: 10.1016/j.yexcr.2020.112109. Epub 2020 May 26.

引用本文的文献

1
Wharton's Jelly Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Intervertebral Disc Degeneration Under Inflammatory Stress in an In Vitro 3D Culture System.沃顿胶间充质基质细胞衍生的细胞外囊泡在体外3D培养系统的炎症应激下减轻椎间盘退变
JOR Spine. 2025 Aug 20;8(3):e70106. doi: 10.1002/jsp2.70106. eCollection 2025 Sep.
2
Therapeutic strategies for intervertebral disc degeneration: Extracellular vesicles and microRNAs derived from mesenchymal stem cells.椎间盘退变的治疗策略:源自间充质干细胞的细胞外囊泡和微小RNA
World J Stem Cells. 2025 Jul 26;17(7):107212. doi: 10.4252/wjsc.v17.i7.107212.
3
A Bibliometric Study of Interleukin Cytokines in the Treatment of Intervertebral Disc Degeneration.白细胞介素细胞因子治疗椎间盘退变的文献计量学研究
Drug Des Devel Ther. 2025 Jul 7;19:5801-5819. doi: 10.2147/DDDT.S523151. eCollection 2025.
4
Bioactive Therapies for Degenerative Disc Disease: Challenges and Innovations.用于退行性椎间盘疾病的生物活性疗法:挑战与创新
World Neurosurg. 2025 Jul;199:124132. doi: 10.1016/j.wneu.2025.124132. Epub 2025 Jun 2.
5
Harnessing the power of stem cell-derived exosomes: a rejuvenating therapeutic for skin and regenerative medicine.利用干细胞衍生外泌体的力量:一种用于皮肤和再生医学的焕肤疗法。
3 Biotech. 2025 Jun;15(6):184. doi: 10.1007/s13205-025-04345-y. Epub 2025 May 23.
6
Exploring extracellular vesicles as novel therapeutic agents for intervertebral disc degeneration: delivery, applications, and mechanisms.探索细胞外囊泡作为椎间盘退变的新型治疗剂:递送、应用及作用机制
Stem Cell Res Ther. 2025 May 1;16(1):221. doi: 10.1186/s13287-025-04299-1.
7
[Mechanism of extracellular vesicles in the repair of intervertebral disc degeneration].[细胞外囊泡在椎间盘退变修复中的机制]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2025 Apr 25;42(2):409-416. doi: 10.7507/1001-5515.202403046.
8
Advancements in Degenerative Disc Disease Treatment: A Regenerative Medicine Approach.退行性椎间盘疾病治疗的进展:一种再生医学方法。
Stem Cell Rev Rep. 2025 Apr 15. doi: 10.1007/s12015-025-10882-z.
9
Nanomedicine Approaches for Intervertebral Disc Regeneration: From Bench to Bedside.用于椎间盘再生的纳米医学方法:从实验台到临床应用
Pharmaceutics. 2025 Feb 28;17(3):313. doi: 10.3390/pharmaceutics17030313.
10
Bone Marrow Mesenchymal Stem Cells-Derived Exosomes Inhibit Apoptosis of Pulmonary Microvascular Endothelial Cells in COPD Mice Through miR-30b/Wnt5a Pathway.骨髓间充质干细胞来源的外泌体通过miR-30b/Wnt5a通路抑制慢性阻塞性肺疾病小鼠肺微血管内皮细胞凋亡
Int J Nanomedicine. 2025 Jan 30;20:1191-1211. doi: 10.2147/IJN.S487097. eCollection 2025.

本文引用的文献

1
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma.抑制SMYD2通过下调微小RNA-125b抑制肿瘤进展并减轻肾细胞癌的多药耐药性。
Theranostics. 2019 Oct 22;9(26):8377-8391. doi: 10.7150/thno.37628. eCollection 2019.
2
Exosomes derived from miR-375-overexpressing human adipose mesenchymal stem cells promote bone regeneration.来源于 miR-375 过表达的人脂肪间充质干细胞的外泌体促进骨再生。
Cell Prolif. 2019 Sep;52(5):e12669. doi: 10.1111/cpr.12669. Epub 2019 Aug 5.
3
Signal Transduction Pathways of Acupuncture for Treating Some Nervous System Diseases.针刺治疗某些神经系统疾病的信号转导通路
Evid Based Complement Alternat Med. 2019 Jul 11;2019:2909632. doi: 10.1155/2019/2909632. eCollection 2019.
4
Differential in vivo biodistribution of I-labeled exosomes from diverse cellular origins and its implication for theranostic application.不同细胞来源的 I 标记外体的体内生物分布差异及其在治疗诊断应用中的意义。
Nanomedicine. 2019 Oct;21:102072. doi: 10.1016/j.nano.2019.102072. Epub 2019 Aug 1.
5
Differential expression and release of exosomal miRNAs by human islets under inflammatory and hypoxic stress.在炎症和缺氧应激下,人胰岛中细胞外体 miRNAs 的差异表达和释放。
Diabetologia. 2019 Oct;62(10):1901-1914. doi: 10.1007/s00125-019-4950-x. Epub 2019 Aug 1.
6
Mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration via anti-oxidant and anti-inflammatory effects.间充质干细胞衍生的外泌体通过抗氧化和抗炎作用改善椎间盘退变。
Free Radic Biol Med. 2019 Nov 1;143:1-15. doi: 10.1016/j.freeradbiomed.2019.07.026. Epub 2019 Jul 24.
7
BRD4 inhibition regulates MAPK, NF-κB signals, and autophagy to suppress MMP-13 expression in diabetic intervertebral disc degeneration.BRD4 抑制调节 MAPK、NF-κB 信号和自噬,以抑制糖尿病性椎间盘退变中 MMP-13 的表达。
FASEB J. 2019 Oct;33(10):11555-11566. doi: 10.1096/fj.201900703R. Epub 2019 Jul 22.
8
Exosomes from mesenchymal stem cells modulate endoplasmic reticulum stress to protect against nucleus pulposus cell death and ameliorate intervertebral disc degeneration in vivo.间充质干细胞来源的外泌体通过调节内质网应激来保护髓核细胞免于死亡,并改善体内椎间盘退变。
Theranostics. 2019 May 31;9(14):4084-4100. doi: 10.7150/thno.33638. eCollection 2019.
9
High glucose promotes annulus fibrosus cell apoptosis through activating the JNK and p38 MAPK pathways.高糖通过激活 JNK 和 p38 MAPK 通路促进纤维环细胞凋亡。
Biosci Rep. 2019 Jul 8;39(7). doi: 10.1042/BSR20190853. Print 2019 Jul 31.
10
Exosomes.外泌体。
Annu Rev Biochem. 2019 Jun 20;88:487-514. doi: 10.1146/annurev-biochem-013118-111902.

间充质干细胞衍生的外泌体通过递送 miR-142-3p 减轻髓核细胞凋亡:治疗椎间盘退行性疾病的潜力。

Mesenchymal stem cells-derived exosomes ameliorate nucleus pulposus cells apoptosis via delivering miR-142-3p: therapeutic potential for intervertebral disc degenerative diseases.

机构信息

Department of Orthopedics, The First Affiliated Hospital of Soochow University , Suzhou, Jiangsu Province, China.

Department of Orthopedics, The Ninth People's Hospital of Suzhou , Suzhou, Jiangsu Province, China.

出版信息

Cell Cycle. 2020 Jul;19(14):1727-1739. doi: 10.1080/15384101.2020.1769301. Epub 2020 Jun 17.

DOI:10.1080/15384101.2020.1769301
PMID:32635856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7469501/
Abstract

Intervertebral disc degeneration (IDD) is the main cause of lower back pain (LBP), and puzzles massive individuals worldwide. Mesenchymal stem cells (MSCs) transplantation has been demonstrated to potentially ameliorate IDD progression, while the underlying mechanism has not been fully explained. Interleukin-1β (IL-1β) was used to induce nucleus pulposus cells (NPCs) injury. Bone marrow MSCs-derived exosomes were isolated using the super centrifugation method, and characterized using Transmission electron microscopy (TEM) and western blot. Cell viability was determined by MTT, while apoptosis was measured by Annexin-V staining using flow cytometry. miR-142-3fp and gene expressions were measured by real-time PCR. The protein expressions were determined by western blot. Herein, we found exosomes from bone marrow MSCs are circular vesicles, about 80 nm in diameter, and with robust expression of TSG101 and CD63, but without of Calnexin. MSCs exosomes alleviated NPCs apoptosis by reducing IL-1β-induced inflammatory cytokines secretion and MAPK signaling activation. Additionally, MSCs exosomes inhibited NPCs apoptosis and MAPK signaling by delivering miR-142-3p that targets mixed lineage kinase 3 (MLK3). Overexpression of MLK3 abolished the effects of MSCs exosomes on the inflammatory condition, cell apoptosis, and MAPK signaling activation in NPCs. The results confirmed that bone marrow MSCs-derived exosomes-packaged miR-142-3p alleviates NPCs injury through suppressing MAPK signaling by targeting MLK3. The work highlights the therapeutic effect of MSCs on IDD progression, and bone marrow MSCs exosomes might be apromising therapeutic strategy for IDD.

摘要

椎间盘退变(IDD)是导致下腰痛(LBP)的主要原因,困扰着全球大量人群。间充质干细胞(MSCs)移植已被证明可能改善 IDD 的进展,但潜在机制尚未完全阐明。本研究采用白细胞介素-1β(IL-1β)诱导髓核细胞(NPCs)损伤。采用超速离心法分离骨髓间充质干细胞来源的外泌体,并通过透射电子显微镜(TEM)和Western blot 进行鉴定。通过 MTT 测定细胞活力,通过流式细胞术用 Annexin-V 染色测定细胞凋亡。通过实时 PCR 测定 miR-142-3fp 和基因表达。通过 Western blot 测定蛋白表达。研究发现,骨髓间充质干细胞来源的外泌体是圆形囊泡,直径约 80nm,具有强烈表达的 TSG101 和 CD63,但没有 Calnexin。MSCs 外泌体通过减少 IL-1β诱导的炎症细胞因子分泌和 MAPK 信号激活来减轻 NPCs 凋亡。此外,MSCs 外泌体通过递送靶向混合谱系激酶 3(MLK3)的 miR-142-3p 抑制 NPCs 凋亡和 MAPK 信号。过表达 MLK3 可消除 MSCs 外泌体对 NPCs 炎症状态、细胞凋亡和 MAPK 信号激活的影响。结果证实,骨髓间充质干细胞来源的外泌体包裹的 miR-142-3p 通过靶向 MLK3 抑制 MAPK 信号来减轻 NPCs 损伤。该研究强调了 MSCs 对 IDD 进展的治疗作用,骨髓间充质干细胞外泌体可能是治疗 IDD 的一种很有前途的治疗策略。